日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities

癌症中的代谢重编程：葡萄糖、脂质和氨基酸通路失调及其治疗契机

期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-026-00427-2
Yu, Mingkang; Yang, Di; Chen, Xiuli; Yang, Yuling; Zhang, Bingqiang; Jiang, Xinxin; Xing, Lijie; Yang, Yuxuan; Sun, Yani; Li, Ning
肿瘤
肿瘤免疫
信号转导
代谢
代谢重编程
发表日期：2026
文献求助 收藏

Polymerase-based DNA reactions for molecularly computing cancerous diagnostic valences of multiple miRNAs.

基于聚合酶的DNA反应，用于分子计算多种miRNA的癌症诊断价值

期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-025-03643-0
Yan Yumin, Zhao Hongyang, Xing Lijie, Ouyang Ye, Zhang Linghao, Yang Jiayu, Qiu Jing, Qian Yongzhong, Ma Liang, Weng Rui, Su Xin
肿瘤
miRNA
发表日期：2025
文献求助 收藏

Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma

病例报告：CD19 和 CD22 CAR-T 疗法使一名难治性浆母细胞淋巴瘤患者获得持久完全缓解

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1697566
Liu, Dan; Wei, Haichen; Hu, Yanran; Wang, Hui; Li, Ping; Lu, Ke; Zhang, Wenjun; Xing, Lijie; Li, Zengjun
淋巴瘤
CD22
细胞生物学
CD2
CD19
发表日期：2025
文献求助 收藏

Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study

Zanubrutinib联合R-CHOP方案治疗新诊断的双表达淋巴瘤：一项II期临床研究

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.35697
Yin, Xia; He, Qiang; Liu, Dan; Xie, Linna; Wang, Hui; Chen, Chunyan; Zhao, Chuanli; Shan, Ningning; Shi, Shanshan; Wei, Haichen; Ma, Ji; Lu, Ke; Wang, Liang; Wang, Yan; Xing, Lijie; Li, Zengjun
CHOP
HOP
淋巴瘤
发表日期：2025
文献求助 收藏

Case Report: Transformation of natural killer-cell large granular lymphocytic leukemia to aggressive natural killer cell leukemia

病例报告：自然杀伤细胞大颗粒淋巴细胞白血病向侵袭性自然杀伤细胞白血病的转化

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1648711
Wang, Wen; Lu, Ke; Xing, Lijie; Li, Zengjun
白血病
细胞生物学
自然杀伤细胞
发表日期：2025
文献求助 收藏

Peripheral T-cell lymphoma with central nervous system involvement and elevated interleukin-10 levels in the cerebrospinal fluid: A case report

外周T细胞淋巴瘤伴中枢神经系统受累及脑脊液中白细胞介素-10水平升高：病例报告

期刊:Precision Radiation Oncology
影响因子:2.1
doi:10.1002/pro6.70018
Wang, Xin; Wei, Haichen; Liu, Dan; Wang, Hui; Li, Zengjun; Xing, Lijie
T细胞
淋巴瘤
神经科学
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment

基于微环境疗法的进展：改变多发性骨髓瘤治疗格局

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1413494
Lu, Ke; Wang, Wen; Liu, Yuntong; Xie, Chao; Liu, Jiye; Xing, Lijie
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma

淋巴瘤患者合并 COVID-19 肺炎的预后风险因素

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1504809
Liu, Dan; Yin, Xia; Wang, Hui; Xing, Lijie; Li, Ping; Wei, Haichen; Ma, Ji; He, Qiang; Xie, Linna; Lu, Ke; Li, Zengjun
肺炎
淋巴瘤
发表日期：2024
文献求助 收藏

Simultaneous determination of triazole fungicides in animal-origin food by ultra-high-performance liquid chromatography coupled with tandem mass spectrometry

采用超高效液相色谱-串联质谱法同时测定动物源性食品中的三唑类杀菌剂

期刊:Food Chemistry-X
影响因子:8.2
doi:10.1016/j.fochx.2023.100956
Xing, Lijie; Liu, Yang; Li, Wenqi; Zou, Liangjun; Wang, Yuan; Luo, Ruifeng
发表日期：2023
文献求助 收藏

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.

γ-分泌酶抑制剂可增强靶向BCMA的双特异性抗体对多发性骨髓瘤细胞的疗效，而不会损害T细胞的活化和分化

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-022-00716-3
Chen Hailin, Yu Tengteng, Lin Liang, Xing Lijie, Cho Shih-Feng, Wen Kenneth, Aardalen Kimberly, Oka Adwait, Lam Joni, Daley Mike, Lu Haihui, Munshi Nikhil, Anderson Kenneth C, Tai Yu-Tzu
细胞生物学
T细胞
发表日期：2022
文献求助 收藏